Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit H Mulsant

Showing results (491-500 of 607) with videos related to

Pageof 61
Sort By:
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
Journal of Psychiatric Research|September 9, 2018
Assessment of neuroplasticity in late-life depression with transcranial magnetic stimulationApoorva Bhandari, Jennifer I Lissemore, Tarek K Rajji, et al.
Ebiomedicine|October 6, 2018
Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD studyNicholas H Neufeld, Benoit H Mulsant, Erin W Dickie, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
Therapeutic Advances in Psychopharmacology|October 22, 2025
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic reviewStanley Wong, Brett D M Jones, Mathura T Thiyagarajah, et al.
Clinical Pharmacology and Therapeutics|January 29, 2024
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with DepressionXiaoyu Men, Zachary L Taylor, Victoria S Marshe, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2019
An inverse relationship between cortical plasticity and cognitive inhibition in late-life depressionJennifer I Lissemore, Hayley R C Shanks, Meryl A Butters, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Bipolar Disorders|May 14, 2019
The Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) project: Understanding older-age bipolar disorder by combining multiple datasetsMartha Sajatovic, Lisa T Eyler, Soham Rej, et al.
Pageof 61

Showing results (491-500 of 607) with videos related to

Sort By:
Pageof 61
Psychopharmacology|August 26, 2016
Lack of association between dopaminergic antagonism and negative symptoms in schizophrenia: a positron emission tomography dopamine D2/3 receptor occupancy studyGagan Fervaha, Fernando Caravaggio, David C Mamo, et al.
Journal of Psychiatric Research|September 9, 2018
Assessment of neuroplasticity in late-life depression with transcranial magnetic stimulationApoorva Bhandari, Jennifer I Lissemore, Tarek K Rajji, et al.
Ebiomedicine|October 6, 2018
Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD studyNicholas H Neufeld, Benoit H Mulsant, Erin W Dickie, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
Therapeutic Advances in Psychopharmacology|October 22, 2025
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic reviewStanley Wong, Brett D M Jones, Mathura T Thiyagarajah, et al.
Clinical Pharmacology and Therapeutics|January 29, 2024
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with DepressionXiaoyu Men, Zachary L Taylor, Victoria S Marshe, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 21, 2023
Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive DisorderVivian Feng, Krista Lanctot, Nathan Herrmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2019
An inverse relationship between cortical plasticity and cognitive inhibition in late-life depressionJennifer I Lissemore, Hayley R C Shanks, Meryl A Butters, et al.
Neuropsychology|August 4, 2022
Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performanceMelissa Milanovic, Chelsea Wood-Ross, Meryl A Butters, et al.
Bipolar Disorders|May 14, 2019
The Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE-BD) project: Understanding older-age bipolar disorder by combining multiple datasetsMartha Sajatovic, Lisa T Eyler, Soham Rej, et al.
Pageof 61